Several clinical and CMR parameters have been identified as indicators of LVRR in DCM, including lack of familial DCM history, TTN gene mutations, female, reduced LVEF, the ratio of the global longitudinal peak strain and the absence of late gadolinium enhancement (LGE), etc. (15, 17–21). This evidence concerns the gene TTN and familial dilated cardiomyopathy.